Before the social network makes automatic videos of your photos, tell it the names of the people you don’t wish to see in the clips.
The Trump administration is working out how to bypass Congress in order to give the rich an easier ride on capital gains.
Mr. Moonves started a civil war by suing the network’s controlling shareholder while knowing that harassment allegations were swirling.
The drive to reduce opioid use has led patients to clinics offering off-label painkiller injections. Pfizer asked the F.D.A. to ban the treatment years ago.
Simon & Schuster plans to publish “Fear: Trump in the White House,” on Sept 11. The book is Mr. Woodward’s 19th.
As second-quarter earnings pour in, executives are telling investors that they can raise prices to offset the impact of tariffs.
Conventional wisdom says the two companies should be blocked from merging to preserve competition and benefit consumers. But the merger could actually create a mightier maverick.
Legislators, officials and activists around the country are rushing to stop a company from posting blueprints for 3-D printed guns this week.
Chris Pratt and other stars derided the “mob mentality” that led Disney to oust the writer-director James Gunn. But just how should studios handle transgressions made during a more anything-goes era?
A U.S. senator and a panel in Britain’s House of Commons have offered some of the first firm suggestions to address issues relating to privacy and misinformation.